Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

JAKAFI for Essential thrombocythaemia: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 18 adverse event reports in the FDA FAERS database where JAKAFI was used for Essential thrombocythaemia.

Most Reported Side Effects for JAKAFI

Side Effect Reports % Deaths Hosp.
Platelet count decreased 165 9.4% 9 28
Fatigue 162 9.3% 6 12
Haemoglobin decreased 150 8.6% 6 19
Anaemia 145 8.3% 5 23
Dizziness 106 6.1% 1 5
Diarrhoea 105 6.0% 4 5
Headache 102 5.8% 1 4
Death 92 5.3% 92 23
Asthenia 74 4.2% 5 14
Nausea 72 4.1% 1 5
Weight increased 70 4.0% 0 4
Blood count abnormal 63 3.6% 1 10
Contusion 61 3.5% 2 1
Dyspnoea 58 3.3% 3 8
Drug dose omission 54 3.1% 2 8

Other Indications for JAKAFI

Myelofibrosis (1,314) Polycythaemia vera (81) Myelodysplastic syndrome (31) Myeloproliferative disorder (29) Splenomegaly (29) Blood disorder (12) Leukaemia (8) Polycythaemia (8) Myeloid metaplasia (6)

Other Drugs Used for Essential thrombocythaemia

RUXOLITINIB (1,788) ANAGRELIDE (797) HYDROXYUREA (629) PEGINTERFERON ALFA-2A (259) ROPEGINTERFERON ALFA-2B-NJFT (123) ASPIRIN (77) PACRITINIB (66) LENALIDOMIDE (41) FEDRATINIB (28) XAGRID (27)

Related Pages

JAKAFI Full Profile All Essential thrombocythaemia Drugs JAKAFI Demographics JAKAFI Timeline